(1)
Tian, X.; Yang, Q.; Wu, J. Effect of Apatinib Mesylate on Clinical Remission Rate and Adverse Reactions in Patients With Advanced Primary Hepatocellular Carcinoma. IJBLS 2024, 5 (1), 13-16. https://doi.org/10.54097/t3s4wp88.